Kathleen R Cho
Peter A. Ward Professor of Pathology
Associate Chair for Academic Affairs
Department of Pathology
Medical Director
Gynecologic Pathology
Professor of Pathology
Professor of Internal Medicine
[email protected]

Available to mentor
Kathleen R Cho
Professor
  • Center Memberships
  • Recent Publications
    • Manage Your Profile
    Center Memberships
    • Center Member
      Rogel Cancer Center
    Recent Publications See All Publications
    • Journal Article
      SOX9 suppresses colon cancer via inhibiting epithelial-mesenchymal transition and SOX2 induction.
      Feng Y, Zhu N, Bedi K, Li J, Perera C, Green M, Assarzadegan N, Zhai Y, Liu Q, Baladandayuthapani V, Spence JR, Cho KR, Fearon ER. J Clin Invest, 2025 Apr 3; DOI:10.1172/JCI184115
      PMID: 40179020
    • Journal Article
      Progestogen-driven B7-H4 contributes to onco-fetal immune tolerance
      Yu J, Yan Y, Li S, Xu Y, Parolia A, Rizvi S, Wang W, Zhai Y, Xiao R, Li X, Liao P, Zhou J, Okla K, Lin H, Lin X, Grove S, Wei S, Vatan L, Hu J, Szumilo J, Kotarski J, Freeman ZT, Skala S, Wicha M, Cho KR, Chinnaiyan AM, Schon S, Wen F, Kryczek I, Wang S, Chen L, Zou W. Cell, 2024 Jul 5; DOI:10.1016/j.cell.2024.06.012
    • Journal Article
      Cell State of Origin Impacts Development of Distinct Endometriosis-Related Ovarian Carcinoma Histotypes
      Beddows I, Fan H, Heinze K, Johnson BK, Leonova A, Senz J, Djirackor S, Cho KR, Pearce CL, Huntsman DG, Anglesio MS, Shen H. Cancer Research, 2024 Jan 1; 184 (1): 26 - 38. DOI:10.1158/0008-5472.CAN-23-1362
      PMID: 37874327
    • Journal Article
      A framework for assessing interactions for risk stratification models: the example of ovarian cancer
      Phung MT, Lee AW, McLean K, Anton-Culver H, Bandera EV, Carney ME, Chang-Claude J, Cramer DW, Doherty JA, Fortner RT, Goodman MT, Harris HR, Jensen A, Modugno F, Moysich KB, Pharoah PDP, Qin B, Terry KL, Titus LJ, Webb PM, Wu AH, Zeinomar N, Ziogas A, Berchuck A, Cho KR, Hanley GE, Meza R, Mukherjee B, Pike MC, Pearce CL, Trabert B. Journal of the National Cancer Institute, 2023 Nov 1; 115 (11): 1420 - 1426. DOI:10.1093/jnci/djad137
      PMID: 37436712
    • Journal Article
      A putative role for ALDH inhibitors and chemoprevention of BRCA-mutation-driven tumors
      McGonigal S, Wu R, Grimley E, Turk EG, Zhai Y, Cho KR, Buckanovich RJ. Gynecologic Oncology, 2023 Sep 1; 176: 139 - 146. DOI:10.1016/j.ygyno.2023.07.015
      PMID: 37535994
    • Chapter
      Cervical cancer
      Straubhar AM, Siedel JH. 2022 Sep 15; Tumor Board Review: Evidence-Based Case Reviews and Questions, 273 - 287. DOI:10.1891/9780826145987.0018
    • Journal Article
      Metabolic collateral lethal target identification reveals MTHFD2 paralogue dependency in ovarian cancer
      Achreja A, Yu T, Mittal A, Choppara S, Animasahun O, Nenwani M, Wuchu F, Meurs N, Mohan A, Jeon JH, Sarangi I, Jayaraman A, Owen S, Kulkarni R, Cusato M, Weinberg F, Kweon HK, Subramanian C, Wicha MS, Merajver SD, Nagrath S, Cho KR, DiFeo A, Lu X, Nagrath D. Nature Metabolism, 2022 Sep 1; 4 (9): 1119 - 1137. DOI:10.1038/s42255-022-00636-3
      PMID: 36131208
    • Presentation
      Ovarian Cancer Pathogenesis: Lessons from Morphology, Molecules, and Mice
      2022 Aug 6;